The Galgotias episode, while rooted in an academic showcase, has thus opened a far wider policy conversation one that now sits at the intersection of ethics, industrial strategy, and patient safety forcing India to confront a critical question: In the race to innovate, how should authenticity be defined, declared, and defended?